Literature DB >> 17095215

Development of SPECT imaging agents for the norepinephrine transporters: [123I]INER.

Gilles D Tamagnan1, Eric Brenner, David Alagille, Julie K Staley, Colin Haile, Andrei Koren, Michelle Early, Ronald M Baldwin, Frank I Tarazi, Ross J Baldessarini, Nachwa Jarkas, Mark M Goodman, John P Seibyl.   

Abstract

A series of reboxetine analogs was synthesized and evaluated for in vitro binding as racemic mixtures. The best candidate (INER) was synthesized as the optically pure (S,S) enantiomer, labeled with iodine-123 and its in vivo binding determined by SPECT imaging in baboons. The in vivo specificity, selectivity, and kinetics of [123I]INER make it a promising agent for imaging NET in vivo by noninvasive SPECT imaging.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17095215      PMCID: PMC1806685          DOI: 10.1016/j.bmcl.2006.10.018

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  19 in total

Review 1.  Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography.

Authors:  Marc Laruelle; Mark Slifstein; Yiyun Huang
Journal:  Mol Imaging Biol       Date:  2003 Nov-Dec       Impact factor: 3.488

2.  Venlafaxine extended release (ER) in the treatment of generalised anxiety disorder: twenty-four-week placebo-controlled dose-ranging study.

Authors:  C Allgulander; D Hackett; E Salinas
Journal:  Br J Psychiatry       Date:  2001-07       Impact factor: 9.319

3.  Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.

Authors:  Mark M Goodman; Ping Chen; Christophe Plisson; Laurent Martarello; James Galt; John R Votaw; Clinton D Kilts; Gene Malveaux; Vernon M Camp; Bing Shi; Timothy D Ely; Leonard Howell; Jon McConathy; Charles B Nemeroff
Journal:  J Med Chem       Date:  2003-03-13       Impact factor: 7.446

4.  Synthesis and in vivo evaluation of novel radiotracers for the in vivo imaging of the norepinephrine transporter.

Authors:  Alan A Wilson; David Patrick Johnson; David Mozley; Doug Hussey; Nathalie Ginovart; Jose Nobrega; Armando Garcia; Jeffery Meyer; Sylvain Houle
Journal:  Nucl Med Biol       Date:  2003-02       Impact factor: 2.408

5.  Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder.

Authors:  Frank P Bymaster; Jason S Katner; David L Nelson; Susan K Hemrick-Luecke; Penny G Threlkeld; John H Heiligenstein; S Michelle Morin; Donald R Gehlert; Kenneth W Perry
Journal:  Neuropsychopharmacology       Date:  2002-11       Impact factor: 7.853

Review 6.  Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder.

Authors:  J Biederman; T Spencer
Journal:  Biol Psychiatry       Date:  1999-11-01       Impact factor: 13.382

7.  Specific in vivo binding to the norepinephrine transporter demonstrated with the PET radioligand, (S,S)-[11C]MeNER.

Authors:  Magnus Schou; Christer Halldin; Judit Sóvágó; Victor W Pike; Balázs Gulyás; P David Mozley; David P Johnson; Håkan Hall; Robert B Innis; Lars Farde
Journal:  Nucl Med Biol       Date:  2003-10       Impact factor: 2.408

8.  Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: possible treatment of Alzheimer's disease.

Authors:  Yasuyuki Abe; Atsushi Aoyagi; Takao Hara; Kazumi Abe; Reina Yamazaki; Yoshihiro Kumagae; Shunji Naruto; Kazuo Koyama; Shinji Marumoto; Keiko Tago; Narihiro Toda; Kazuko Takami; Naho Yamada; Mayuko Ori; Hiroshi Kogen; Tsugio Kaneko
Journal:  J Pharmacol Sci       Date:  2003-09       Impact factor: 3.337

9.  PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain.

Authors:  Magnus Schou; Christer Halldin; Judit Sóvágó; Victor W Pike; Håkan Hall; Balázs Gulyás; P David Mozley; David Dobson; E Shchukin; Robert B Innis; Lars Farde
Journal:  Synapse       Date:  2004-08       Impact factor: 2.562

10.  Synthesis and evaluation of radioiodinated (S,S)-2-(alpha-(2-iodophenoxy)benzyl)morpholine for imaging brain norepinephrine transporter.

Authors:  Naoki Kanegawa; Yasushi Kiyono; Hiroyuki Kimura; Taku Sugita; Satomi Kajiyama; Hidekazu Kawashima; Masashi Ueda; Yuji Kuge; Hideo Saji
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-08       Impact factor: 9.236

View more
  3 in total

1.  (R)-N-Methyl-3-(3'-[F]fluoropropyl)phenoxy)-3-phenylpropanamine (F-MFP3) as a potential PET imaging agent for norepinephrine transporter.

Authors:  Vivien L Nguyen; Rama Pichika; Paayal H Bhakta; Ritu Kant; Jogeshwar Mukherjee
Journal:  J Labelled Comp Radiopharm       Date:  2010-02-09       Impact factor: 1.921

2.  (R)-N-Methyl-3-(3-(125)I-pyridin-2-yloxy)-3-phenylpropan-1-amine: a novel probe for norepinephrine transporters.

Authors:  Balagopal Lakshmi; Mei-Ping Kung; Brian Lieberman; Jun Zhao; Rikki Waterhouse; Hank F Kung
Journal:  Nucl Med Biol       Date:  2007-11-19       Impact factor: 2.408

3.  Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.

Authors:  Fanxing Zeng; Jiyoung Mun; Nachwa Jarkas; Jeffrey S Stehouwer; Ronald J Voll; Gilles D Tamagnan; Leonard Howell; John R Votaw; Clinton D Kilts; Charles B Nemeroff; Mark M Goodman
Journal:  J Med Chem       Date:  2009-01-08       Impact factor: 7.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.